Biliary proteins inhibiting or promoting cholesterol crystallization are assumed to play a major role in cholesterol gallstone pathogenesis. We now report a new group of biliary proteins that bind to cholesterol crystals, modify crystal morphology, and inhibit cholesterol crystallization. Various glycoprotein mixtures were extracted from abnormal human gallbladder bile using lectin affinity chromatography on concanavalin A, lentil, and Helix pomatia columns and were added to supersaturated model bile. Independent of the protein mixtures added, from the cholesterol crystals harvested, the same four GPs were isolated having molecular masses of 16, 28, 63, and 74 kD, respectively. Each protein was purified using preparative SDS-PAGE, and influence on cholesterol crystallization in model bile was tested at 10 microg/ml. Crystal growth was reduced by 76% (GP63), 65% (GP16), 55% (GP74), and 40% (GP28), respectively. Thus, these glycoproteins are the most potent biliary inhibitors of cholesterol crystallization known so far. Evidence that the inhibiting effect on cholesterol crystallization is mediated via protein-crystal interaction was further provided from scanning electron microscopy studies. Crystals grown in presence of inhibiting proteins showed significantly more ordered structures. Incidence of triclinic crystals and regular aggregates was shifted from 30 to 70% compared with controls. These observations may have important implications for understanding the role of biliary proteins in cholesterol crystallization and gallstone pathogenesis.
N Busch, F Lammert, H U Marschall, S Matern
Title and authors | Publication | Year |
---|---|---|
Ultramorphological analysis of plaque advancement and cholesterol crystal formation in Ldlr knockout mouse atherosclerosis
Y Baumer, S McCurdy, X Jin, TM Weatherby, AK Dey, NN Mehta, JK Yap, HS Kruth, WA Boisvert |
Atherosclerosis | 2019 |
Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis
Y Baumer, S McCurdy, TM Weatherby, NN Mehta, S Halbherr, P Halbherr, N Yamazaki, WA Boisvert |
Nature Communications | 2017 |
Gallstone disease
HU Marschall, C Einarsson |
Journal of Internal Medicine | 2007 |
Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations
JG Mella, R Schirin-Sokhan, A Rigotti, F Pimentel, L Villarroel, HE Wasmuth, T Sauerbruch, F Nervi, F Lammert, JF Miquel |
Journal of lipid research | 2007 |
Pathways of cholesterol crystallization in model bile and native bile
P Portincasa, A Moschetta, KJ Erpecum, G Calamita, A Margari, GP vanBerge-Henegouwen, G Palasciano |
Digestive and Liver Disease | 2003 |
Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy
F Lammert, S Südfeld, N Busch, S Matern |
World journal of gastroenterology : WJG | 2002 |
Quantitation of cholesterol crystallization from supersaturated model bile
P Portincasa, NG Venneman, A Moschetta, A van den Berg, G Palasciano, GP vanBerge-Henegouwen, KJ van Erpecum |
Journal of lipid research | 2002 |
Cholesterol crystal binding of biliary immuno-globulin A: visualization by fluorescence light microscopy
F Lammert |
World journal of gastroenterology : WJG | 2001 |
Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones
U Gustafsson, S Sahlin, C Einarsson |
European Journal of Clinical Investigation | 2000 |
Composition and immunofluorescence studies of biliary “sludge” in patients with cholesterol or mixed gallstones
PL de la Porte, H Lafont, N Domingo, G Meyer, I Müller, B Zündt, D Jüngst |
Journal of Hepatology | 2000 |
Electrophoretic analysis of proteins in bile
C He, S Fischer, GA Kullak-Ublick, N Domingo, H Lafont, D Jüngst |
Analytica Chimica Acta | 1999 |
Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells
R Secknus, G Darby, A Chernosky, T Juvonen, E Moore, RT Holzbach |
Journal of Gastroenterology and Hepatology | 1999 |
PHYSICAL AND METABOLIC FACTORS IN GALLSTONE PATHOGENESIS
JM Donovan |
Gastroenterology Clinics of North America | 1999 |
Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis
YC Keulemans, KS Mok, JF Slors, MA Brink, DJ Gouma, GN Tytgat, AK Groen |
Journal of Hepatology | 1999 |
Hakata Antigen, a New Member of the Ficolin/Opsonin p35 Family, Is a Novel Human Lectin Secreted into Bronchus/Alveolus and Bile
M Akaiwa, Y Yae, R Sugimoto, SO Suzuki, T Iwaki, K Izuhara, N Hamasaki |
Journal of Histochemistry & Cytochemistry | 1999 |
Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins
N Busch, F Lammert, S Matern |
Gastroenterology | 1998 |
Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization
T Nishioka, S Tazuma, G Yamashita, G Kajiyama |
Biochemical Journal | 1998 |
Effects of serpins on cholesterol crystallization in model bile
S Janciauskiene, MC Gerbord, S Lindgren |
Journal of Hepatology | 1998 |
The pathogenesis of cholesterol gallstones—a review
S Strasberg |
Journal of Gastrointestinal Surgery | 1998 |
The role of Concanavalin A-binding fraction in cholesterol crystallization in native human bile
YC Keulemans, KS Mok, DJ Gouma, AK Groen |
Journal of Hepatology | 1997 |
Comparison of haptoglobin and apolipoprotein A-I on biliary lipid particles involved in cholesterol crystallization
G Yamashita, R Secknus, A Chernosky, KA Krivacic, RT Holzbach |
Journal of Gastroenterology and Hepatology | 1996 |
GALLSTONE FORMATION
IA Bouchier |
The Lancet | 1971 |